UR CTSI Funds Investigation of Novel Drug Targeting Cancer Microenvironment

A team of researchers at the Wilmot Cancer Institute hopes to lay the foundation for a novel cancer therapy that would target the cancer microenvironment with funding from a UR CTSI Incubator Award.

Digital Health Seedling: Using Wearable Tech to Speed ALS Diagnosis and Study Autism Stressors

Digital health technologies are changing the way we study health and treat diseases. The first two projects awarded a Digital Health Seedling from the UR CTSI are studying how wearable sensors might help detect ALS earlier and help us understand and avoid stress among children with autism and their parents.

2021 Pilot Studies Investigate Breastmilk Fortifiers, Refine Therapies for Jaw Bone Loss, Dystonia

Our 2021 Pilot Awardees have just kicked off their new studies ranging from an investigation of new breast milk fortifiers for neonates to refining a stem-cell therapy for jaw bone loss and identifying biomarkers to streamline optimization of treatment for patients with dystonia.

UR CTSI Funding Leads to New Grant for Childhood Tooth Decay Prevention App

URMC researchers are building on previous funding from the UR CTSI to develop a smartphone app that can detect and prevent severe tooth decay in underserved kids and improve their overall well-being.

Blood Cancer Research Moves from Lab to Clinic with UR CTSI Help

With the help of a UR CTSI Incubator Award, Wilmot Cancer Institute researcher Laura Calvi, M.D, has translated discoveries from the lab to a clinical trial that has begun to help patients with blood cancer.